HER-2 Positive Breast Cancer Active Not Recruiting Phase 2 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02675231A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerTreatment